These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19559720)

  • 41. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
    Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
    J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of age and gender on dose and effectiveness of botulinum toxin for laryngeal dystonia.
    Vasconcelos S; Birkent H; Sardesai MG; Merati AL; Hillel AD
    Laryngoscope; 2009 Oct; 119(10):2004-7. PubMed ID: 19572275
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of a New Botulinum Toxin Type A Free of Complexing Proteins.
    Oh HM; Park JH; Song DH; Chung ME
    Toxins (Basel); 2015 Dec; 8(1):. PubMed ID: 26712786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Mechanisms of neuro-tropic disorders induced in skeletal muscles by botulinum toxin].
    Mikhaĭlov VV
    Biull Eksp Biol Med; 1980 Jul; 89(7):25-7. PubMed ID: 7407365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An improved electrophysiological method to study peripheral nerve regeneration in rats.
    Werdin F; Grüssinger H; Jaminet P; Kraus A; Manoli T; Danker T; Guenther E; Haerlec M; Schaller HE; Sinis N
    J Neurosci Methods; 2009 Aug; 182(1):71-7. PubMed ID: 19505504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative Pharmacodynamics Study of 3 Different Botulinum Toxin Type A Preparations in Mice.
    Kwak S; Kang WH; Rhee CH; Yang GH; Cruz DJM
    Dermatol Surg; 2020 Dec; 46(12):e132-e138. PubMed ID: 32251006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays.
    Rupp D; Nicholson G; Canty D; Wang J; Rhéaume C; Le L; Steward LE; Washburn M; Jacky BP; Broide RS; Philipp-Dormston WG; Brin MF; Brideau-Andersen A
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32545832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of non-invasive and invasive techniques in the treatment of patients with myofascial pain syndrome].
    Gül K; Onal SA
    Agri; 2009 Jul; 21(3):104-12. PubMed ID: 19780001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The combined use of forced cold air and topical anesthetic cream for analgesia during the treatment of palmar hyperhydrosis with botulinum toxin injections.
    Patel R; Halem M; Zaiac M
    J Drugs Dermatol; 2009 Oct; 8(10):948-51. PubMed ID: 19852126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An initial assessment of the systemic pharmacokinetics of botulinum toxin.
    Ravichandran E; Gong Y; Al Saleem FH; Ancharski DM; Joshi SG; Simpson LL
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1343-51. PubMed ID: 16782822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
    Kanovský P; Bares M; Severa S; Richardson A;
    Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of severe achalasia during pregnancy with esophagoscopic injection of botulinum toxin A: a case report.
    Wataganara T; Leelakusolvong S; Sunsaneevithayakul P; Vantanasiri C
    J Perinatol; 2009 Sep; 29(9):637-9. PubMed ID: 19710656
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysport: pharmacological properties and factors that influence toxin action.
    Pickett A
    Toxicon; 2009 Oct; 54(5):683-9. PubMed ID: 19332087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Influence of neuromuscular blockade on motor evoked potential of forearm muscles].
    Chen N; Zhou SJ; Yan HC; Xie Z
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):445-8. PubMed ID: 19567090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of systemic handling in the pathophysiologic actions of botulinum toxin.
    Al-Saleem FH; Ancharski DM; Ravichandran E; Joshi SG; Singh AK; Gong Y; Simpson LL
    J Pharmacol Exp Ther; 2008 Sep; 326(3):856-63. PubMed ID: 18539649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of vaccines against leading biowarfare toxins can utilize DNA scientific technology.
    Middlebrook JL
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1415-23. PubMed ID: 15896873
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrodiagnosis of botulism and clinico-electrophysiological correlation.
    Witoonpanich R; Vichayanrat E; Tantisiriwit K; Rattanasiri S; Ingsathit A
    Clin Neurophysiol; 2009 Jun; 120(6):1135-8. PubMed ID: 19410507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prolonged compound muscle action potential duration in critical illness myopathy.
    Goodman BP; Harper CM; Boon AJ
    Muscle Nerve; 2009 Dec; 40(6):1040-2. PubMed ID: 19813187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
    Siddiqui NY; Amundsen CL; Visco AG; Myers ER; Wu JM
    J Urol; 2009 Dec; 182(6):2799-804. PubMed ID: 19837427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rosewood oil induces sedation and inhibits compound action potential in rodents.
    de Almeida RN; Araújo DA; Gonçalves JC; Montenegro FC; de Sousa DP; Leite JR; Mattei R; Benedito MA; de Carvalho JG; Cruz JS; Maia JG
    J Ethnopharmacol; 2009 Jul; 124(3):440-3. PubMed ID: 19505550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.